NATERA, INC. Other Non-Current Liabilities
NATERA, INC. (NTRA) had Other Non-Current Liabilities of $25.26 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-07
- 2026-06-30: Other Liabilities, Noncurrent $25.26M.
- 2026-03-31: Other Liabilities, Noncurrent $16.27M.
- 2025-12-31: Other Liabilities, Noncurrent $11.69M.
- 2024-12-31: Other Liabilities, Noncurrent $7.84M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $25.26M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $16.27M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $11.69M 10-Q · filed 2026-08-07 |
| 2024-12-31 | $7.84M 10-K · filed 2026-02-27 |
| 2022-06-30 | $3.62M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $2.53M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $1.48M 10-K · filed 2023-03-01 |
| 2021-09-30 | $1.46M 10-Q · filed 2021-11-05 |
| 2020-12-31 | $320.00K 10-K · filed 2022-02-25 |
| 2020-09-30 | $310.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $310.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $310.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $310.00K 10-K · filed 2021-02-26 |
| 2017-12-31 | $1.33M 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |